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OBJECTIVE: The level of hemoglobin A1c (HbA1c), also known as glycated hemoglobin, determines how well a
patient’s blood glucose level has been controlled over the previous 8–12 weeks. HbA1c levels help patients and
doctors understand whether a particular diabetes treatment is working and whether adjustments need to be made
to the treatment. Because the HbA1c level is a marker of blood glucose for the previous 60–90 days, average blood
glucose levels can be estimated using HbA1c levels. Our aim in the present study was to investigate the relationship
between estimated average glucose levels, as calculated by HbA1c levels, and fasting plasma glucose levels.
METHODS: The fasting plasma glucose levels of 3891 diabetic patient samples (1497 male, 2394 female) were
obtained from the laboratory information system at the Izmir Bozyaka Training and Research Hospital in Turkey.
These samples were selected from patient samples that had hemoglobin levels between 12 and 16 g/dL. The
estimated glucose levels were calculated using the following formula: 28.7 x HbA1c – 46.7. Glucose and HbA1c levels
were determined using hexokinase and high performance liquid chromatography (HPLC) methods, respectively.
RESULTS: A strong positive correlation between fasting plasma glucose levels and estimated average blood glucose
levels (r=0.757, p,0.05) was observed. The difference was statistically significant.
CONCLUSION: Reporting the estimated average glucose level together with the HbA1c level is believed to assist
patients and doctors determine the effectiveness of blood glucose control measures.
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INTRODUCTION
The management of diabetes mellitus requires an accurate
evaluation of blood glucose control to assess the efficiency
of a particular therapy. Whole blood hemoglobin A1c
(HbA1c) measurements have been widely used in diabetes
patients for more than 25 years to monitor long-term
glycemic control.
1,2 The measurement indicates a patient’s
average blood glucose level during the previous 60–90 days.
It is recommended that diabetes patients have their HbA1c
levels checked at least two times per year because
quantitative and direct relationships have been identified
between HbA1c concentration and the risk of diabetic
microvascular complications.
3 Therefore, clinicians use
HbA1c test results to guide treatment decisions, and the
test has become the cornerstone for assessing diabetes care.
4
Various analytical methods based on different assay
techniques, such as ion-exchange chromatography, affinity
chromatography, immunoassays and electrophoresis, have
been used to measure glycated hemoglobin levels.
5 As a
result, HbA1c results can vary considerably when measured
by different laboratories or methods. Recently, the
International Federation of Clinical Chemistry and
Laboratory Medicine (IFCC) developed a new reference
method that specifically measures the concentration of a
single molecular species of glycated A1c.
4 However, the new
method results in values that are 1.5%–2.0% lower than
current values, and the results are expressed in different
units (millimoles per mole of unglycated hemoglobin),
which may cause confusion for patients and health care
providers.
6
The relationship between the mean blood glucose level
and the level of HbA1c has been investigated in different
studies, and various equations have been obtained.
2,7,8
Using Nathan’s regression equation, which has been
recommended by the American Diabetes Association
(ADA), the estimated average glucose (eAG) level calcula-
tion and its relationship to the fasting plasma glucose (FPG)
level were investigated in the present study.
MATERIALS AND METHODS
The fasting plasma glucose levels of 3891 diabetic patient
samples (1497 male, 2394 female) were obtained from a
laboratory information system at the Izmir Bozyaka
Training and Research Hospital in Turkey. Blood samples
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1077were taken on the same day for the determination of both
FPG and HbA1c. The study group was selected from patient
samples that had hemoglobin levels between 12 and
16 g/dL because HbA1c results can be influenced by
several factors, including anemia. In addition, samples from
patients with hemoglobin abnormalities or uremia or who
were pregnant were excluded. The estimated glucose levels
(mg/dL) were calculated using the following formula: 28.7 x
HbA1c – 46.7.
6 According to the patients’ levels of blood
glucose control, we divided the samples into three groups:
group A: FPG , 126 mg/dL; group B: FPG=126–200 mg/
dL; and group C: FPG . 200 mg/dL. Glucose levels were
determined using the hexokinase method in an Olympus
2700 analyzer with commercially available Olympus kits
(Olympus Optical Co. Ltd, Shizuoka-ken, Japan). HbA1c
levels were determined using an HPLC method and an
Agilent Technologies 1200 Series analyzer with commer-
cially available kits (Chromsystems Instruments and
Chemicals GmbH, Mu ¨nchen, Germany). Hemoglobin (Hb)
levels were determined using a Beckman Coulter Gen S
system (Beckman Coulter Inc., Fullerton, CA, USA).
All statistical analyses were performed using the
Statistical Package for Social Sciences (SPSS, version 11.0
for Windows, Chicago, IL, USA). Data were expressed as
the means ¡ standart error of the mean (SEM). A p-value
,0.05 was accepted as significant. The Kolmogorov-
Smirnov test was performed to assess the normality of the
variables. The Wilcoxon signed-rank test was used to
compare the FPG and eAG levels, and the Mann-Whitney
U test was used to compare the variables between males
and females. The Spearman correlation coefficient (r) was
used to test the relationship between the FPG and eAG
levels.
RESULTS
According to the Kolmogorov-Smirnov test, the distribu-
tions of age, HbA1c, FPG, eAG and Hb were abnormal
(p,0.05). The study group consisted of 3891 individuals
with a mean age of 56.5 ¡0.2 (ranging from 18 to 92 years
old) (Table1). The mean FPG, eAG, HbA1c and Hb levels in
the whole group presented in Table1. A strong positive
correlation was found between FPG and eAG levels
(r=0.757, p,0.05).
Although the mean levels of FPG and eAG were close,
according to the Wilcoxon signed-rank test, they were
statistically significantly different (p,0.05).
The mean age and the HbA1c, FPG, eAG and Hb levels in
groups A, B and C are shown in Table1. The similarities in
the average levels of FPG and eAG that were present for the
group as a whole disappeared when the patient samples
were separated into groups A, B and C. The correlation
coefficients for these groups are presented in Table1
(p,0.05). The eAG levels were higher in groups A and B
than in group C compared to FPG levels.
The relationship between the levels of FPG and eAG was
investigated for males and females using Spearman’s
correlation coefficients after verifying the normality of
variables with the Kolmogorov-Smirnov test. The correla-
tion coefficient was higher in women (r= 0.779) than in men
(r=0.723) (p,0.05). In addition, the mean levels of FPG,
eAG, HbA1c and Hb were higher in males than in females
(Table2). A statistically significant difference was found for
eAG, HbA1c and Hb levels between men and women
(Table2).
DISCUSSION
The HbA1c measurement is used to determine the
average level of glycemic control over the previous 8–12
weeks; this measurement is accepted as a gold-standard
measurement of chronic glycemia.
4 Despite its wide inter-
national use, there is a substantial lack of standardization
among HbA1c determination methods. The desire to
standardize the HbA1c results obtained from different
techniques led the IFCC to create a reference method, but
this method created problems in reporting measurement
results.
7 One problem is the risk of decreasing a patient’s
glycemic control; when a patient’s HbA1c measurement is
lower than previous results, he or she might become
confused and perhaps change diet, which could negatively
impact his or her metabolic control.
9 The other problem is
the reporting of HbA1c levels in mmol HbA1c per mol total
Hb, which could confuse patients. In addition, guidelines
for diabetes have been based on standard levels that are
derived from reports of the Diabetes Control and
Complications Trial (DCCT) and the U.K. Prospective
Diabetes Study (UKPDS). The equivalent of the current
HbA1c targets of 6.5% and 7.5% are 48 milimoles per mole
and 59 milimoles per mole in the new units. To resolve these
problems, the ADA, the European Association for the Study
of Diabetes (EASD) and the International Diabetes
Federation (IDF) sponsored an international study to define
a mathematical relationship between HbA1c and the eAG
level.
6 The following formula describes this relationship:
28.7 x HbA1c - 46.7 = eAG. This formula will assist health
care providers and their patients in interpreting HbA1c
values in units similar to those that the patients see
regularly through self-monitoring.
6
Using this formula, we calculated the eAG levels of our
study group and investigated their relationship with the
FPG levels. Surprisingly, the eAG levels were closely
Table 1 - The levels of the glycemic parameters and the
correlation coefficients for all groups (mean ¡SEM).
Entire
group
Group A FPG:
, 126 mg/dL
Group B FPG:
126–200 mg/dL
Group C FPG:
. 200 mg/dL
N 3891 1736 1313 842
Age (y) 56.5 ¡0.2 54.7 ¡0.3 58.8 ¡0.3 56.6 ¡0.4
FPG (mg/dL) 159.4 ¡0.9 103.2 ¡0.3 155.3 ¡0.6 281.7 ¡2.3
eAG (mg/dL) 159.7 ¡1.2 125.1 ¡0.7 160.6 ¡1.0 229.6 ¡1.9
Hb (g/dL) 13.7 ¡0.02 13.6 ¡0.02 13.7 ¡0.02 13.8 ¡0.04
HbA1c (%) 7.2 ¡0.03 6.0 ¡0.02 7.2 ¡0.04 9.6 ¡0.07
FPG vs. eAG r = 0.757 r = 0.300 r = 0.443 r = 0.450
Table 2 - A comparison of the glycemic parameter levels
in males and females (mean ¡SEM).
Male Female p-value
n 1497 2394
Age (y) 56.4 ¡0.3 56.5 ¡0.3 0.711
FPG (mg/dL) 160.4 ¡2.0 158.7 ¡1.55 0.374
eAG (mg/dL) 162.8 ¡1.5 157.6 ¡1.1 0.001
Hb (g/dL) 14.2 ¡0.03 13.3 ¡0.02 0.001
HbA1c (%) 7.3 ¡0.05 7.1 ¡0.04 0.001
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1078associated with the FPG levels when the measurements
were taken the same day. There was not only a strong
correlation between the eAG and FPG levels, but their mean
levels were also very similar (159.7 mg/dL and 159.4 mg/
dL, respectively). We at first thought that the eAG and FPG
levels could be used interchangeably. It appeared that
determining a patient’s HbA1c level might be unnecessary if
we could determine his or her FPG level because we could
simply calculate it with the aforementioned formula. We
decided to directly compare the eAG and FPG levels
statistically. Although their mean levels seemed to be
similar, they were actually significantly different
(p=0.001). Although we observed a significant difference
between the average levels, this difference was not clinically
meaningful. For 1567 samples, the eAG levels were lower
than the FPG levels, whereas for 2324 samples, the eAG
levels were higher than the FPG levels. These findings
clearly demonstrate that the eAG and FPG values cannot be
used interchangeably. We accepted the similar means of the
eAG and FPG levels as a coincidence. This similarity in the
FPG and eAG levels for the entire group disappeared when
the subgroups were separated according to FPG level. In
addition, the decrease in the significant strong correlation
coefficient showed that the association depended on the
patients’ levels of glucose control. As glucose control
worsened, the association became stronger.
On the other hand, most patients who come to the clinic
for plasma glucose determination pay more attention to
fasting and diet rules. The eAG levels in the study group
were higher than the FPG levels not only because patients
come to the lab in a fasting state but also because the eAG
level is reflective of all plasma glucose levels over the
previous three months, including the postprandial glucose
levels. Sixty percent of patients had higher eAG levels than
FPG levels. When we evaluated the eAG levels of patients in
group C, we found that their eAG levels were lower than
their FPG levels, in contrast with the findings for groups A
and B (Table1). We assumed that patients with higher FPG
levels experienced stress before coming to the hospital to
give blood or did not take their anti-diabetic drugs, since
their FPG levels were higher than their average blood
glucose levels.
We also wanted to understand the effect of gender on the
eAG and FPG levels. Among age-matched samples, females
had lower eAG and FPG levels than males (Table2). The
decreased levels of eAG and HbA1c in women were
significantly different from those of males. In addition,
there was a significant difference between the eAG and FPG
levels in both men and women (p=0.000). The eAG levels of
females and males were higher than the FPG levels in most
patients (58% and 62%, respectively), similar to the results
found for the group as a whole (60%).
The IDF estimates that 285 million people worldwide
have diabetes. This total number is expected to rise to 438
million within 20 years. Turkey, with approximately 70
million inhabitants, is a country where diabetes and
impaired glucose tolerance are moderately common, but
awareness of diabetes remains poor.
10 It is thought that
diabetic patients require better strategies to improve self-
management.
11 One of these strategies is the use of eAG
levels together with HbA1c values. Although the clinical
usefulness of eAG is not clear,
12,13 we believe that every
patient’s eAG level should be calculated and reported along
with his or her HbA1c level. This strategy will help patients
better understand the importance of keeping their blood
glucose levels within acceptable limits and maybe will
rescue them from some invasive approaches for glucose
homeostasis.
14
CONCLUSION
According to our data, patients with good to moderate
blood glucose control are not entirely successful at mana-
ging their blood glucose, as reflected by their eAG levels,
and the association between the FPG and eAG levels
depends on the extent of blood glucose control.
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